TeleDocs360 Tirzepatide Review: Cost & Honest Verdict (2026)

TeleDocs360 is a cash-pay telehealth service requiring a live video visit before any prescription — a stricter clinical standard than many compounded telehealths — with transparent $399/month base pricing. Every fact here comes from the company's own published program.

What TeleDocs360 is

TeleDocs360 is a cash-pay telehealth service, offering compounded GLP-1 weight-loss medications including injectable semaglutide and tirzepatide, oral semaglutide, plus phentermine and NAD+ therapy. A live video visit is required before a prescription, with 24-hour prescription approval afterward.

What TeleDocs360 costs

Base pricing for standard dosing runs a transparent $399/month, with higher doses increasing cost. HSA/FSA cards are accepted.

The brand-vs-compounded question

TeleDocs360 dispenses compounded medications only — no FDA-approved branded options. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

TeleDocs360's real strengths is a required live video visit before prescribing — real clinical oversight, transparent base pricing, multiple GLP-1 delivery options including oral semaglutide, HSA/FSA card acceptance, and cancel-anytime between shipments. The trade-offs: it's compounded only, no state availability list is published, no individual provider credentials or board certifications are shown, and higher doses increase cost beyond the base rate. As with any GLP-1 program, confirm your specific dose price and state eligibility before your video visit; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

TeleDocs360's required video visit and transparent base pricing are real positives, but the missing provider credentials and unnamed pharmacy are worth asking about directly. For a provider with named clinical leadership and a genuinely verified LegitScript seal, compare it against TeleClinic or Ondra Health. See our best tirzepatide providers ranking for the full field.